MCID: INT060
MIFTS: 40

Intestinal Atresia malady

Category: Gastrointestinal diseases

Aliases & Classifications for Intestinal Atresia

About this section

Summaries for Intestinal Atresia

About this section
Wikipedia:70 Intestinal atresia is a malformation where there is a narrowing or absence of a portion of the... more...

MalaCards based summary: Intestinal Atresia is related to peters anomaly and umbilical cord ulceration and intestinal atresia. An important gene associated with Intestinal Atresia is TTC7A (Tetratricopeptide Repeat Domain 7A), and among its related pathways are Heart Development and Galactose metabolism. Affiliated tissues include small intestine, liver and heart, and related mouse phenotypes are pigmentation and digestive/alimentary.

Related Diseases for Intestinal Atresia

About this section

Diseases related to Intestinal Atresia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idRelated DiseaseScoreTop Affiliating Genes
1peters anomaly28.1FOXC1, PAX6, PITX2
2umbilical cord ulceration and intestinal atresia12.3
3pancreatic hypoplasia, intestinal atresia, and gallbladder aplasia or hypoplasia, with or without tracheoesophageal fistula11.9
4gastrointestinal defects and immunodeficiency syndrome11.8
5mitchell-riley syndrome11.5
6jejunal atresia11.2
7atresia of small intestine11.2
8ciliary dyskinesia, primary, 3111.0
9gastroschisis10.1
10intussusception10.0
11proximal chromosome 18q deletion syndrome10.0GCK, PDX1
12hyperlipoproteinemia type iv10.0GCK, PDX1
13microcephaly9.9
14diaphanospondylodysostosis9.9GCK, PDX1
15ring dermoid of cornea9.9FOXC1, PITX2
16severe combined immunodeficiency9.8
17chronic tympanitis9.8FOXC1, PITX2
18peritonitis9.8
19inclusion body myopathy with paget disease of bone and frontotemporal dementia9.7GCK, PDX1
20meconium ileus9.7
21jejunoileitis9.7
22omphalocele9.7
23imperforate anus9.7
24short bowel syndrome9.7
25intestinal obstruction9.7
26intestinal volvulus9.7
27duodenitis9.7
28glaucoma 3a, primary open angle, congenital, juvenile, or adult onset9.6FOXC1, PAX6
29frias syndrome9.5
30feingold syndrome9.5
31hemochromatosis9.5
32alagille syndrome9.5
33duodenal atresia9.5
34pulmonary hypertension9.5
35glomerulonephritis9.5
36hepatitis9.5
37umbilical hernia9.5
38neonatal diabetes mellitus9.5
39esophagitis9.5
40cholestasis9.5
41biliary atresia9.5
42extrahepatic cholestasis9.5
43thrombophilia9.5
44angiodysplasia9.5
45neuronitis9.5
46polyhydramnios9.5
47meckel's diverticulum9.5
48encephalocele9.5
49transposition of the great arteries9.5
50isolated growth hormone deficiency, type ib, gh1-related9.3FOXC1, PAX6, PITX2

Graphical network of the top 20 diseases related to Intestinal Atresia:



Diseases related to intestinal atresia

Symptoms for Intestinal Atresia

About this section

Drugs & Therapeutics for Intestinal Atresia

About this section

Drugs for Intestinal Atresia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bosentanapproved, investigationalPhase 2103147536-97-8104865
Synonyms:
-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
147536-97-8
174227-18-0
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide
4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
AC-148
AC1L2XN2
Actelion
Bosentan
Bosentan (INN)
Bosentan [USAN:INN:BAN]
Bosentan hydrate
C27H29N5O6S
CHEBI:51450
CHEMBL957
CID104865
D07538
DB00559
 
EN002863
HMS2090N14
I06-1873
KS-5062
L001086
LS-31532
MolPort-003-845-300
NCGC00167440-01
PDSP1_001731
PDSP2_001714
Ro 47-0203
Ro 47-0203/039
Ro-47-0203
Ro-47-0203/029
Ro-47-0203/039
TL8001039
Tracleer
UNII-XUL93R30K2
bosentan
bosentanum
bosentán
p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
p-tert-Butyl-N-[6-(2-hydroxyethoxy)
2Liver ExtractsPhase 23868
3Pharmaceutical SolutionsPhase 27793
4Antihypertensive AgentsPhase 24095
5Endothelin Receptor AntagonistsPhase 2215
6Parenteral Nutrition SolutionsPhase 2153
7Protective AgentsPhase 27190
8Fat Emulsions, IntravenousPhase 292
9AntioxidantsPhase 22928
10
BilirubinPhase 2112635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
11Soybean oil, phospholipid emulsionPhase 273
12Hormone AntagonistsPhase 1, Phase 212778
13IncretinsPhase 1, Phase 21537
14Glucagon-Like Peptide 1Phase 1, Phase 2694
15Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 212767
16HormonesPhase 1, Phase 213979
17glucagonPhase 1, Phase 2462
18Gastrointestinal AgentsPhase 1, Phase 28109
19Omega 3 Fatty AcidNutraceuticalPhase 2969
20Soy BeanNutraceuticalPhase 2535
21
VancomycinapprovedPhase 13221404-90-6441141, 14969
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
1404-90-6
1404-93-9 (hydrochloride)
64685-75-2 (sulfate)
AC1L24VU
AC1L9AMI
AC1Q29OH
BIDD:GT0353
C06689
C66H75Cl2N9O24
CHEBI:28001
CHEMBL262777
CID14969
CID441141
CID5311496
CID6426898
CID6917992
D00212
DB00512
EINECS 215-772-6
HSDB 3262
LMPK14000004
 
LS-161387
Lopac0_001267
MolPort-001-794-649
NCGC00162383-02
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
SPBio_002314
UNII-6Q205EH1VU
VAN
VANCOMYCIN
Vancocin
Vancocin (TN)
Vancocin HCL
Vancomicina
Vancomicina [INN-Spanish]
Vancomycin
Vancomycin (USP)
Vancomycin HCL
Vancomycin [USAN:INN:BAN]
Vancomycine
Vancomycine [INN-French]
Vancomycinum
Vancomycinum [INN-Latin]
nchembio.350-comp1
22Anti-Bacterial AgentsPhase 110884
23Anti-Infective AgentsPhase 121402
24
Neomycinapproved, vet_approved481404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
25Vitamins5095
26Trace Elements5802
27Micronutrients5802
28Alpha 1-Antitrypsin99
29Protein C Inhibitor97
30Bile Acids and Salts102
31glutamineNutraceutical151
32AcidophilusNutraceutical518
33lysineNutraceutical90
34alanineNutraceutical121
35ColaNutraceutical1881

Interventional clinical trials:

(show all 17)
idNameStatusNCT IDPhase
1Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.CompletedNCT01292551Phase 2
2Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
3Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1, Phase 2
4Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinCompletedNCT01322386Phase 1
5Treating Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinRecruitingNCT02137668Phase 1
6Determination of Lysine Requirement in the Parenterally Fed NeonateCompletedNCT00779753
7Esophageal Atresia: Metaplasia, BarrettCompletedNCT02495051
8Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai PortoenterostomyCompletedNCT00166868
9Modified Perfusion for Neonatal Aortic Arch ReconstructionCompletedNCT00490256
10Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary AtresiaCompletedNCT01063699
11Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome InfantsCompletedNCT01576003
12Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary AtresiaRecruitingNCT01745991
13Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)RecruitingNCT00571272
143D High Resolution Anorectal Manometry in Children After Surgery for Anorectal DisordersRecruitingNCT02296008
15Molecular Genetics of Heterotaxy and Related Congenital Heart DefectsRecruitingNCT02432079
16Long-term Outcome in Patients With Anorectal MalformationsNot yet recruitingNCT02624232
17Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Intestinal Atresia


Cochrane evidence based reviews: intestinal atresia

Genetic Tests for Intestinal Atresia

About this section

Genetic tests related to Intestinal Atresia:

id Genetic test Affiliating Genes
1 Intestinal Atresia26

Anatomical Context for Intestinal Atresia

About this section

MalaCards organs/tissues related to Intestinal Atresia:

35
Small intestine, Liver, Heart, Smooth muscle, Pancreas, Colon, Brain

Animal Models for Intestinal Atresia or affiliated genes

About this section

MGI Mouse Phenotypes related to Intestinal Atresia:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.5FOXC1, PAX6, PITX2, TTC7A
2MP:00053819.0FOXC1, PAX6, PDX1, PITX2, TTC7A
3MP:00053698.8CENPF, FOXC1, PAX6, PDX1, PITX2
4MP:00053708.6FOXC1, GCK, PDX1, PITX2, TTC7A
5MP:00053798.1FOXC1, GCK, PAX6, PDX1, PITX2, TTC7A
6MP:00053677.8FOXC1, GCK, PAX6, PDX1, TTC7A
7MP:00053787.7CENPF, FOXC1, GCK, PAX6, PDX1, PITX2
8MP:00107687.7CENPF, FOXC1, GCK, PAX6, PDX1, PITX2

Publications for Intestinal Atresia

About this section

Articles related to Intestinal Atresia:

(show top 50)    (show all 237)
idTitleAuthorsYear
1
Correction: the complex surgical management of the first case of severe combined immunodeficiency and multiple intestinal atresias surviving after the fourth year of life. (25866737)
2015
2
Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with multiple intestinal atresia and combined immunodeficiency. (24931897)
2014
3
Population-based study of esophageal and small intestinal atresia/stenosis. (24730728)
2014
4
Ascites, anemia and (intestinal) atresia. (24374868)
2014
5
Intestinal atresia occurring in association with placental fetal thrombotic vasculopathy: a case report with literature review. (22989172)
2013
6
Apple-peel intestinal atresia: enteroplasty for intestinal lengthening and primary anastomosis. (23845656)
2013
7
Laparoscopy-assisted surgery for neonatal intestinal atresia and stenosis: a report of 35 cases. (23143134)
2012
8
Multiple intestinal anastomoses to avoid short bowel syndrome and stimulate bowel maturity in type IV multiple intestinal atresia and necrotizing enterocolitis. (22424368)
2012
9
Intestinal atresia and ectopia in a bovine fetus. (20926733)
2011
10
Multiple intestinal atresias associated with angiodysplasia in a newborn. (21763851)
2011
11
Intestinal atresia, encephalocele, and cardiac malformations in infants with 47,XXX: Expansion of the phenotypic spectrum and a review of the literature. (20160426)
2010
12
Neonatal hemochromatosis and Martinez-Frias syndrome of intestinal atresia and diabetes mellitus in a consanguineous newborn. (19887127)
2010
13
Catheter enterostomy and patch repair of the abdominal wall for gastroschisis with intestinal atresia: report of a case. (19639444)
2009
14
Different types of intestinal atresia in identical twins. (19040960)
2008
15
A further example of a distinctive autosomal recessive syndrome comprising neonatal diabetes mellitus, intestinal atresias and gall bladder agenesis. (18512226)
2008
16
Morphological abnormalities in the innervation of the atretic segment of bowel in neonates with intestinal atresia. (17955249)
2007
17
A possible association between maternal glomerulonephritis and congenital intestinal atresia/stenosis--a population-based case-control study. (17569014)
2007
18
Small intestinal atresia in a defined population: occurrence, prenatal diagnosis and survival. (17994616)
2007
19
Umbilical hernia associated with extracelomic intestinal atresia and perforation of the ileum in a newborn. (17568164)
2007
20
The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresia. (16410122)
2006
21
Observations on the origin of congenital intestinal atresia. (17077911)
2006
22
Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome. (15592663)
2004
23
Intestinal atresia presenting as bilateral scrotal pneumatocele: A case report. (11782011)
2002
24
Intestinal atresia: an end-to-end linear anastomotic technique. (11727065)
2001
25
Congenital small bowel diverticulosis and intestinal atresia: a rare association. (10770404)
2000
26
Umbilical cord ulcer: a serious in utero complication of intestinal atresia. (10833382)
2000
27
Congenital intestinal atresia in a Kerry blue terrier. (10563244)
1999
28
Alterations of the intramural nervous distributions in a chick intestinal atresia model. (9890605)
1999
29
Mesenteric defects as a cause of intestinal volvulus without malrotation and as the possible primary etiology of intestinal atresia. (8786519)
1995
30
Intestinal bilious vomiting--an unusual presentation of intestinal atresia in the newborn. (7625312)
1994
31
Hereditary multiple intestinal atresia--ultrasound findings and outcome of pregnancy in an affected case. (8183838)
1994
32
Umbilical cord ulceration in association with intestinal atresia in a child with deletion 13q and Hirschsprung's disease. (7820720)
1994
33
Delayed presentation of intestinal atresia and intussusception--a case report and literature review. (8292584)
1993
34
Intrauterine intussusception as a cause of intestinal atresia. (1452326)
1992
35
A 13q- syndrome with extensive intestinal atresia. (3993382)
1985
36
Intestinal atresia (report of 4 cases). (6481656)
1984
37
Congenital intestinal atresia of calves. (6874504)
1983
38
Operative mangement of intestinal atresia and stenosis based on pathologic findings. (480102)
1979
39
Comparison of histochemical studies of intestinal atresia in the human newborn and fetal lamb. (90142)
1979
40
Gastroschisis complicated by intestinal atresia. (142311)
1977
41
Duodenojejunal atresia with "apple-peel" small bowel. A distinct form of intestinal atresia. (1251017)
1976
42
Small intestinal atresia: the critical role of a functioning anastomosis. (4207350)
1974
43
Extensive intramural intestinal calcification in a newborn with intestinal atresia. Case report. (4695912)
1973
44
Intestinal atresia in calves. (4777215)
1973
45
Vomiting in utero with intestinal atresia. (4556279)
1972
46
Experimental intestinal atresia in the rabbit fetus. Sequential pathological studies. (5081731)
1972
47
Effect of changing concepts upon the diagnosis and management of intestinal atresia. (5538726)
1971
48
Small intestinal atresia. (5577678)
1971
49
The occurrence of intestinal atresia in newborns with meconium ileus. The pathogenesis of an acquired anomaly. (13799829)
1960
50
Congenital intestinal atresia. (14351730)
1955

Variations for Intestinal Atresia

About this section

Expression for genes affiliated with Intestinal Atresia

About this section
Search GEO for disease gene expression data for Intestinal Atresia.

GO Terms for genes affiliated with Intestinal Atresia

About this section

Biological processes related to Intestinal Atresia according to GeneCards Suite gene sharing:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1lacrimal gland developmentGO:003280810.3FOXC1, PAX6
2iris morphogenesisGO:006107210.2PAX6, PITX2
3eye developmentGO:000165410.1FOXC1, PAX6
4pituitary gland developmentGO:002198310.0PAX6, PITX2
5type B pancreatic cell differentiationGO:000330910.0PAX6, PDX1
6positive regulation of DNA bindingGO:004338810.0PDX1, PITX2
7odontogenesis of dentin-containing toothGO:004247510.0FOXC1, PITX2
8blood vessel developmentGO:00015689.9FOXC1, PAX6
9response to woundingGO:00096119.8PAX6, PDX1
10detection of glucoseGO:00515949.7GCK, PDX1
11smoothened signaling pathwayGO:00072249.7PAX6, PDX1
12camera-type eye developmentGO:00430109.5FOXC1, PAX6, PITX2
13regulation of cell migrationGO:00303349.4PAX6, PITX2
14glucose metabolic processGO:00060069.3GCK, PDX1
15animal organ morphogenesisGO:00098879.3PAX6, PDX1, PITX2
16positive regulation of insulin secretionGO:00320249.2GCK, PDX1
17brain developmentGO:00074209.1FOXC1, PAX6, PITX2
18glucose homeostasisGO:00425938.9GCK, PAX6, PDX1
19transcription from RNA polymerase II promoterGO:00063668.7FOXC1, PAX6, PDX1, PITX2
20positive regulation of transcription, DNA-templatedGO:00458938.6FOXC1, PAX6, PDX1, PITX2
21positive regulation of transcription from RNA polymerase II promoterGO:00459448.5FOXC1, PAX6, PDX1, PITX2

Molecular functions related to Intestinal Atresia according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1transcription factor activity, RNA polymerase II distal enhancer sequence-specific bindingGO:000370510.0FOXC1, PDX1
2RNA polymerase II transcription factor activity, sequence-specific DNA bindingGO:00009819.3FOXC1, PAX6, PITX2
3RNA polymerase II core promoter proximal region sequence-specific DNA bindingGO:00009789.0PAX6, PDX1, PITX2
4transcription factor activity, sequence-specific DNA bindingGO:00037008.5FOXC1, PAX6, PDX1, PITX2
5chromatin bindingGO:00036828.5CENPF, PAX6, PDX1, PITX2
6sequence-specific DNA bindingGO:00435658.2FOXC1, PAX6, PDX1, PITX2
7transcription factor bindingGO:00081348.1CENPF, FOXC1, PAX6, PDX1, PITX2

Sources for Intestinal Atresia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet